Koefisien utang jangka dawa marang modal Cuprina Holdings Limited (CUPR)

Simbol lan logo merek Cuprina Holdings (Cayman) Ltd (CUPR)

Cuprina Holdings (Cayman) Ltd (CUPR) relies on defensive demand for the treatment of diabetic ulcers, rendering its revenues crisis-resistant. Unique patents for larval therapy create a barrier to entry for new players. The team is currently scaling the business globally, and this chart on GURU.Markets illustrates the dynamics of the long-term debt-to-equity ratio, where the 0.07 mark records this metric.

CUPR Cuprina Holdings: Utang jangka dawa marang modal ing interval 11.04.2025 - 01.11.2026
Produk dadi Cuprina Holdings

This ratio determines the financial stability of the issuer through the balance of long-term liabilities and equity. The metric measures the proportion of borrowed funds with a maturity exceeding one year, allowing for an assessment of bankruptcy risks against expansion rates. The current long-term debt-to-equity ratio demonstrates the financing strategy of Cuprina Holdings (Cayman) Ltd (CUPR). Optimizing this leverage is critical to offset rising logistics costs in Southeast Asia. Debt control provides the company with protection during supply chain disruptions of copper components.

Analisis perusahaan pesaing

HCA (HCA Holdings) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Tenet (THC)|FMS (Fresenius Medical) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal SOLV (Solventum Corporation)|encompasshealth.com (EHC) - Kewajiban jangka dawa marang modal|Universal Health Services Corp - Utang jangka dawa marang modal|DVA - Utang jangka dawa marang modal|RDNT (RadNet Corp) - Rasio utang jangka dawa marang ekuitas|OPCH: Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Surgery Partners, Inc.|Rasio utang jangka dawa marang ekuitas premierinc.com (PINC)|Utang jangka dawa marang modal EYE|PGNY - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Ardent Health Partners Inc ARDT|SEM: Rasio utang jangka dawa marang modal|ASTH: Rasio utang jangka dawa marang ekuitas|Pediatrix Medical Group, Inc. - Rasio silihan jangka dawa marang modal|USPH: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Pennant Group|Rasio utang jangka dawa marang ekuitas ORGO|Utang jangka dawa marang modal Nutex Health Hospitals|Utang jangka dawa marang ekuitas Auna SA (AUNA)|SBC: Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Evolus EOLS|Koefisien utang jangka dawa marang modal CYH|Beauty Health - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal MediWound Ltd. MDWD|biote Corp. (BTMD) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal JYNT|DCGO (DocGo) - Utang jangka dawa marang modal|Utang jangka dawa marang modal P3 Health|Rasio utang jangka dawa marang ekuitas GANX (Gain Therapeutics, Inc.)|EUDA (euda.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal BMGL (Basel Medical Group Ltd)|Koefisien utang jangka dawa marang modal CLGN|CCM - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal American Shared Hospital Services Inc|MEDIROM Healthcare Group Inc (MRM) - Utang jangka dawa marang ekuitas|ALBT (Avalon GloboCare Corp.) - Utang jangka dawa marang ekuitas|DHAI (DIH Holding US, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal XAGE (carmellcosmetics.com)|Utang jangka dawa marang modal NIVF|Rasio tanggungan utang jangka dawa marang modal atipt.com|Utang jangka dawa marang ekuitas CareMax Medical Group CMAX|KDLY: Rasio utang jangka dawa marang modal|ModivCare Inc. - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas novointegrated.com (NVOS)|sunlinkhealth.com (SSY) - Utang jangka dawa marang ekuitas|BACK - Rasio tanggungan utang jangka dawa marang modal